Table 1

Baseline Characteristics of Patients in the Development and Validation Cohorts

CharacteristicDevelopment Cohort (n = 203)Validation Cohort (n = 415)
Unfavorable dizziness course,a No. (%)150 (73.9)181 (43.6)
Female, No. (%)127 (62.6)305 (73.5)
Age, mean (SD), y77.5 (7.0)78.5 (7.1)
Number of chronic diseases, mean (SD)1.8 (1.4)2.1 (1.4)
Number of drugs used, mean (SD)5.5 (3.6)4.4 (3.0)
Dizziness characteristics
DHI score,b mean (SD) [range]46.2 (13.4) [30–88]36.1 (19.9) [0–88]
Time since onset of dizziness, No. (%)
 0–4 weeks3 (1.5)29 (7.0)
 1–6 months34 (16.7)98 (23.6)
 6–48 months49 (24.1)109 (26.3)
 2–10 years74 (36.5)120 (28.9)
 >10 years42 (21.2)59 (14.2)
Description of dizziness, No. (%)c
 Instability or unsteadiness162 (79.8)280 (67.5)
 Loss of balance165 (81.3)287 (69.2)
 Lightheadedness145 (71.4)247 (59.5)
 Rotational sensation137 (67.5)228 (54.9)
 Tendency to fall135 (66.5)225 (54.2)
 Giddy115 (56.7)176 (42.2)
 Environment spinning84 (41.4)137 (33.0)
 Becoming unwell60 (29.6)114 (27.5)
 Near faint59 (29.1)96 (23.1)
 Everything turning black39 (19.2)68 (16.4)
  • DHI = Dizziness Handicap Inventory.

  • a At 6 months of follow-up.

  • b Score ranges from 0 to 100, with higher scores indicating more severe dizziness-related impairment.

  • c Adds up to more than 100% because more than 1 answer was allowed.